Galderma

The Galderma S. A. is a Swiss pharmaceutical company based in Lausanne.

Business

The product portfolio and research and development are focused on the area of ​​dermatology. The product range includes drugs to treat diseases of the skin, hair and nails.

In Sophia Antipolis (France), Princeton (New Jersey) and Tokyo Galderma has ever a research and development center. Production facilities are located in Alby- sur- Chéran (France ), Montreal (Canada) and Hortolândia ( Brazil).

The company has 31 offices on five continents. The German branch trades as Galderma Laboratorium GmbH and has its headquarters in Dusseldorf.

Company History

Galderma was founded in 1981 as a joint venture between Nestlé and L' Oréal. Seven years later, the joint venture acquired the dermatological areas of Alcon, which was acquired by Nestlé in 1977. In 1995, Galderma Differin Acne therapy with the (active ingredient adapalene ), the first self-developed drugs to market. The Basotherm GmbH, a subsidiary of Boehringer Ingelheim was acquired in 1997. With Silkis (active ingredient calcitriol ) was launched in 2000 a cure for psoriasis on the market. 2001 Galderma acquired an exclusive license for the manufacture and distribution of Metvix (active substance: methyl -5-amino -4- oxopentanoate ) of the Norwegian company Photocure. 2003 saw the sale of Metvix. 2008 CollaGenex Pharmaceuticals with the brand Oracea, a treatment for rosacea (active ingredient doxycycline) were adopted. The anti -wrinkle agent Azzalure (active ingredient: botulinum toxin ) has been placed on the European market in 2009. 2011, the company Q -Med has been adopted, based in Uppsala (Sweden). Q -Med has been active in the field of breast augmentation by means of injections of hyaluronic acid.